Show simple item record

Authordc.contributor.authorRedal, María A. 
Authordc.contributor.authorQuiñones Sepúlveda, Luis 
Admission datedc.date.accessioned2019-05-29T13:59:12Z
Available datedc.date.available2019-05-29T13:59:12Z
Publication datedc.date.issued2017
Cita de ítemdc.identifier.citationEn: Pharmacogenomics in Latin America: Challenges and Opportunities, 2017. pp. 229-238
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/169167
Abstractdc.description.abstractThe ultimate goal of pharmacogenomic research is to predict individual's responses to drug therapy and subsequently adapt pharmacotherapeutic strategies. Therefore, the current challenge for personalized therapy is to define genetic profiles to predict the response to drugs and the progression of the diseases. However, despite the enormous amount of known information about the genetic basis of variable response to drugs, it has little influence on its application to the current clinical practice, particularly in Latin American region where there is a great genetic admixture. Thus, the present chapter pursues to contribute with a general vision of the future of the area to overcome the proper limitations of this region.
Lenguagedc.language.isoen
Publisherdc.publisherNova Science
Sourcedc.sourcePharmacogenomics in Latin America: Challenges and Opportunities
Keywordsdc.subjectEthnicity
Keywordsdc.subjectLatin America
Keywordsdc.subjectPharmacogenetics
Keywordsdc.subjectPharmacogenomics
Keywordsdc.subjectPharmagenes
Títulodc.titleFuture directions: challenges, opportunities and limitations
Document typedc.typeCapítulo de libro
dcterms.accessRightsdcterms.accessRightsAcceso a solo metadatos
Catalogueruchile.catalogadorlaj
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record